Summary
Arthur Allignol is a biostatistician and data scientist with 12 years of experience leading evidence generation and real-world data analysis in the pharmaceutical industry, currently serving as Director of Evidence Generation Biostatistics at Daiichi Sankyo Europe. He holds a PhD in Biostatistics and brings deep expertise in complex survival endpoints from a research career that included a postdoc at Ulm University and roles in clinical trial units. Arthur builds and maintains widely used R tools for event history analysis (author of etm, mvna, Cprob, kmi and co-maintainer of the CRAN Survival Task View), bridging methodological innovation with applied regulatory and real-world evidence needs. He has progressed from hands-on biostatistician to strategic leader, driving reproducible analytics across observational and clinical studies. A not-obvious strength is his sustained commitment to community knowledge-sharing through open-source maintenance that informs both academic methods and industry practice.
12 years of coding experience
15 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Biostatistics, Doctor of Philosophy (Ph.D.) Biostatistics at The University of Freiburg
English, German, French, Spanish